“…Additionally, signal intensity of T1 and STIRT2 images were not useful for monitoring response to chemotherapy because most of the treatment-induced changes seen on MRI were not specific (2,5). Even in the present study, the DWI was also evaluated in bone metastases secondary to prostate cancer (27). After chemotherapy, ADC values decreased in some lesions and increased in others, both in responders and nonresponders.…”